Lv1
30 积分 2023-11-11 加入
An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis
6个月前
已完结
Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies
6个月前
已完结
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer
6个月前
已完结
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial
6个月前
已完结
皖公网安备34019202002308
